Paper28958807
Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
Schiffer JT and 1 other. Vaccine, 2019. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Papers, record 28958807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28958807
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| Herpes Simplex Virus Vaccines | Major topic |
| Herpesvirus 2, Human | Major topic |
| Animals | |
| HIV Infections | |
| Herpes Genitalis | |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed | PubMed | |
| R01 AI121129 | NIAID NIH HHS | United States | R01AI121129 | PubMed and NIH | NIH RePORTER |
| UM1 AI068635 | NIAID NIH HHS | United States | UM1AI068635 | PubMed and NIH | NIH RePORTER |
References129
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22701511 | Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine. | Future Virol | 2012 | https://conductscience.org/library/papers/22701511 | PubMed |
| 2 | 28044388 | Langerhans cells and sexual transmission of HIV and HSV. | Rev Med Virol | 2017 | https://conductscience.org/library/papers/28044388 | PubMed |
| 3 | 19702506 | Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19702506 | PubMed |
| 4 | 18572080 | Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. | Lancet | 2008 | https://conductscience.org/library/papers/18572080 | PubMed |
| 5 | 20161655 | Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. | Sci Transl Med | 2009 | https://conductscience.org/library/papers/20161655 | PubMed |
| 6 | 17360672 | Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360672 | PubMed |
| 7 | 22214845 | Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22214845 | PubMed |
| 8 | 24554666 | Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection. | J Virol | 2014 | https://conductscience.org/library/papers/24554666 | PubMed |
| 9 | 27922851 | Future prospects for new vaccines against sexually transmitted infections. | Curr Opin Infect Dis | 2017 | https://conductscience.org/library/papers/27922851 | PubMed |
| 10 | 21173243 | Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21173243 | PubMed |
| 11 | 26670699 | Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2. | PLoS One | 2015 | https://conductscience.org/library/papers/26670699 | PubMed |
| 12 | 25994965 | Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge. | J Immunol | 2015 | https://conductscience.org/library/papers/25994965 | PubMed |
| 13 | 17306567 | Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Immunity | 2007 | https://conductscience.org/library/papers/17306567 | PubMed |
| 14 | 19071187 | Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. | Vaccine | 2009 | https://conductscience.org/library/papers/19071187 | PubMed |
| 15 | 9108946 | Concurrent partnerships and the spread of HIV. | AIDS | 1997 | https://conductscience.org/library/papers/9108946 | PubMed |
| 16 | 24016811 | Current status and prospects for development of an HSV vaccine. | Vaccine | 2014 | https://conductscience.org/library/papers/24016811 | PubMed |
| 17 | 25734115 | Incidence of herpes simplex virus type 2 infections in Africa: a systematic review. | Open Forum Infect Dis | 2014 | https://conductscience.org/library/papers/25734115 | PubMed |
| 18 | 12567178 | Natural history of genital herpes simplex virus type 1 infection. | Sex Transm Dis | 2003 | https://conductscience.org/library/papers/12567178 | PubMed |
| 19 | 22561365 | Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). | J Infect Dis | 2012 | https://conductscience.org/library/papers/22561365 | PubMed |
| 20 | 20588163 | Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. | AIDS | 2010 | https://conductscience.org/library/papers/20588163 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944036 | Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment. | Viruses | 2026 | https://conductscience.org/library/papers/42944036 | PubMed |
| 42292461 | Progress and prospects for herpesvirus vaccination using gB antigens. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292461 | PubMed |
| 42199433 | Bispecific antibodies targeting herpes simplex virus glycoproteins B and D. | Front Immunol | 2026 | https://conductscience.org/library/papers/42199433 | PubMed |
| 40684179 | Small molecule UCM05 inhibits HSV-2 infection via targeting viral glycoproteins and fatty acid synthase with potentiating antiviral immunity. | Virol J | 2025 | https://conductscience.org/library/papers/40684179 | PubMed |
| 40328740 | A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing. | Nat Commun | 2025 | https://conductscience.org/library/papers/40328740 | PubMed |
| 40007004 | Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy. | Viruses | 2025 | https://conductscience.org/library/papers/40007004 | PubMed |
| 39681948 | Estimated global and regional economic burden of genital herpes simplex virus infection among 15-49 year-olds in 2016. | BMC Glob Public Health | 2024 | https://conductscience.org/library/papers/39681948 | PubMed |
| 39459934 | Herpes Simplex Virus Type 2 Blocks IFN-β Production through the Viral UL24 N-Terminal Domain-Mediated Inhibition of IRF-3 Phosphorylation. | Viruses | 2024 | https://conductscience.org/library/papers/39459934 | PubMed |
| 39207577 | A review of HSV pathogenesis, vaccine development, and advanced applications. | Mol Biomed | 2024 | https://conductscience.org/library/papers/39207577 | PubMed |
| 39066200 | Small Animal Models to Study Herpes Simplex Virus Infections. | Viruses | 2024 | https://conductscience.org/library/papers/39066200 | PubMed |
| 38606611 | Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium at pharyngeal and anorectal sites in patients presenting to an STI outpatient ward. | J Eur Acad Dermatol Venereol | 2025 | https://conductscience.org/library/papers/38606611 | PubMed |
| 38005873 | The Interplay of Genital Herpes with Cellular Processes: A Pathogenesis and Therapeutic Perspective. | Viruses | 2023 | https://conductscience.org/library/papers/38005873 | PubMed |
| 37894118 | Enhanced Anti-Herpetic Activity of Valacyclovir Loaded in Sulfobutyl-ether-β-cyclodextrin-decorated Chitosan Nanodroplets. | Microorganisms | 2023 | https://conductscience.org/library/papers/37894118 | PubMed |
| 36926608 | Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action. | J Ginseng Res | 2023 | https://conductscience.org/library/papers/36926608 | PubMed |
| 36520853 | Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study. | PLoS Med | 2022 | https://conductscience.org/library/papers/36520853 | PubMed |
| 36016177 | CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36016177 | PubMed |
| 33664729 | Poly(dA:dT) Suppresses HSV-2 Infection of Human Cervical Epithelial Cells Through RIG-I Activation. | Front Immunol | 2020 | https://conductscience.org/library/papers/33664729 | PubMed |
| 32937282 | Antiviral potential of natural products from marine microbes. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32937282 | PubMed |
| 32758172 | Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32758172 | PubMed |
| 32717979 | Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties. | Molecules | 2020 | https://conductscience.org/library/papers/32717979 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACKR1 | 2532 | PubTator's text mining | https://conductscience.org/library/genes/2532 | NCBI Gene |
| CCR5 | 1234 | PubTator's text mining | https://conductscience.org/library/genes/1234 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| HFM1 | 164045 | PubTator's text mining | https://conductscience.org/library/genes/164045 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28958807
GET https://conductscience.org/api/papers/v1/28958807/references?page=2